PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PEN vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PEN and BSX is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

PEN vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
37.16%
26.05%
PEN
BSX

Key characteristics

Sharpe Ratio

PEN:

0.07

BSX:

3.57

Sortino Ratio

PEN:

0.37

BSX:

4.89

Omega Ratio

PEN:

1.04

BSX:

1.65

Calmar Ratio

PEN:

0.05

BSX:

8.63

Martin Ratio

PEN:

0.11

BSX:

35.79

Ulcer Index

PEN:

23.26%

BSX:

1.73%

Daily Std Dev

PEN:

38.43%

BSX:

17.31%

Max Drawdown

PEN:

-62.64%

BSX:

-89.15%

Current Drawdown

PEN:

-23.36%

BSX:

0.00%

Fundamentals

Market Cap

PEN:

$10.12B

BSX:

$145.41B

EPS

PEN:

$0.87

BSX:

$1.21

PE Ratio

PEN:

303.09

BSX:

81.54

PEG Ratio

PEN:

-62.27

BSX:

1.79

Total Revenue (TTM)

PEN:

$879.10M

BSX:

$12.19B

Gross Profit (TTM)

PEN:

$539.30M

BSX:

$8.13B

EBITDA (TTM)

PEN:

-$6.00M

BSX:

$2.85B

Returns By Period

In the year-to-date period, PEN achieves a 11.04% return, which is significantly higher than BSX's 10.46% return.


PEN

YTD

11.04%

1M

10.38%

6M

38.88%

1Y

3.08%

5Y*

10.48%

10Y*

N/A

BSX

YTD

10.46%

1M

11.28%

6M

27.20%

1Y

61.90%

5Y*

17.42%

10Y*

21.29%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PEN vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
The Risk-Adjusted Performance Rank of PEN is 4646
Overall Rank
The Sharpe Ratio Rank of PEN is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 4343
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 4141
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 4848
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 4747
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9999
Overall Rank
The Sharpe Ratio Rank of BSX is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9898
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9797
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9999
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PEN vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PEN, currently valued at 0.07, compared to the broader market-2.000.002.004.000.073.57
The chart of Sortino ratio for PEN, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.000.374.89
The chart of Omega ratio for PEN, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.65
The chart of Calmar ratio for PEN, currently valued at 0.05, compared to the broader market0.002.004.006.000.058.63
The chart of Martin ratio for PEN, currently valued at 0.11, compared to the broader market-10.000.0010.0020.0030.000.1135.79
PEN
BSX

The current PEN Sharpe Ratio is 0.07, which is lower than the BSX Sharpe Ratio of 3.57. The chart below compares the historical Sharpe Ratios of PEN and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
0.07
3.57
PEN
BSX

Dividends

PEN vs. BSX - Dividend Comparison

Neither PEN nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PEN vs. BSX - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for PEN and BSX. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-23.36%
0
PEN
BSX

Volatility

PEN vs. BSX - Volatility Comparison

Penumbra, Inc. (PEN) has a higher volatility of 9.81% compared to Boston Scientific Corporation (BSX) at 6.18%. This indicates that PEN's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
9.81%
6.18%
PEN
BSX

Financials

PEN vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab